Baker Bros. Advisors LP 13D/13G Filings for Global Blood Therapeutics, Inc. (GBT)

Baker Bros. Advisors LP 13D and 13G filings for Global Blood Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
4:14 pm
Purchase
2021-12-31 13G Global Blood Therapeutics, Inc.
GBT
Baker Bros. Advisors LP 3,314,765
5.100%
3,314,765increase
(New Position)
Filing